Foreword
Bioprocess Innovation
Defining the future of medicine
The future of healthcare is being shaped not only in research laboratories and hospitals but also within the rapidly
Manufacturing
Beyond Scientific Breakthroughs in Radiopharmaceuticals
Innovating on execution
Radiopharmaceuticals once considered a niche modality are now being positioned alongside mainstream oncology strategies
Information Technology
AI and Computational Modeling Approaches for Dose Optimisation During Drug Development
Computational modeling and artificial intelligence are transforming how pharmaceutical developers determine optimal drug doses By mathematically predicting drug behavior and therapeutic effectsrather than guessing from limited datathese approaches enable developers to identify the right dose for each patient reducing trialanderror and delivering be...
FROM ALGORITHMS TO BIOLOGY
Validating AI-discovered targets and molecules in translational oncology
The landscape of drug discovery is undergoing a profound transformation moving from serendipitous observations
Beyond Human Intuition
AI-Driven platforms and the future of Molecular Binding Design
In late Nabla Bio demonstrated the first computationally designed antibodies capable of binding G proteincoupled receptors
Artificial Intelligence (AI)
From promise to practice
As a Head of PV I reached a straightforward conclusion manual processing is a compliance risk not just an inefficiency
Harnessing AI to Revolutionise Drug Discovery and Development
Conventional drug discovery follows a linear and resourceintensive process target identification hit discovery lead optimisation
Expert Corner
Reimagining Pharmacovigilance
AI-driven, human-led global drug safety
Over the next decade pharmacovigilance will evolve from a compliancedriven reactive function into a proactive safety
Beyond Perfect Patients
How patient journey intelligence is revolutionising clinical trial success
After speaking to more than industry leaders I believe at the core of it is a reliance on decontextualised historical data
Rethinking Inflammation
Implications for next-generation therapies
Inflammation is now recognised as a core biological process that when dysregulated contributes to a wide spectrum of chronic
How Innovation in Bioprocessing is Shaping the Future of Medicine
Bioprocessing has undergone a remarkable shift in recent years driven by technologies that enable faster smarter
Reinvent Drug Development and Safety with AI
AI technologies are influencing nearly every stage of the drug development lifecycle from early discovery to postmarket monitoring
Advertorials
Shaping Tomorrow’s Pharma with Sustainable Solutions
Advanced Separation, Thermal Efficiency & Hygienic Processing
As the pharmaceutical industry scales up to meet global demand manufacturers are under growing
Where Generics Win
Pharmaceutical ingredients that make the difference
Excipients play an essential role in pharmaceutical formulations than theyre often given credit for so what do they really
Pharma Reimagined
The strategic evolution of CPHI & PMEC China
As the epicentre of the AsiaPacific pharmaceutical market CPHI PMEC China serves attendees
EMLy™
The AI platform turning months of biologics engineering into days
When Michelle Teng and Jacob Hurst cofounded Etcembly in the problem they were setting out to solve was one
BioPharma
Beyond Trial and Error
How precision tools and AI are de-Risking drug discovery and development
A decade of research and billions invested can vanish overnight with a single latestage trial failure a story all too familiar
